The current FBLG market cap is 38.47M. The company's latest EPS is USD -0.5499 and P/E is -2.09.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 0 | 0 |
Operating Income | -4.47M | -8.89M |
Net Income | -5.12M | -19.06M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 4.82M | 11.82M |
Total Liabilities | 8.82M | 10.57M |
Total Equity | -4M | 1.25M |
Market Cap | 38.47M |
Price to Earnings Ratio | -2.09 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.35 |
Price to Book Ratio | 31.81 |
Dividend Yield | - |
Shares Outstanding | 34.66M |
Average Volume (1 week) | 689.98k |
Average Volume (1 Month) | 553.93k |
52 Week Change | -92.34% |
52 Week High | 14.70 |
52 Week Low | 1.06 |
Spread (Intraday) | 0.16 (12.6%) |
Company Name | FibroBiologics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.fibrobiologics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions